PARKINSONS DISEASE
Clinical trials for PARKINSONS DISEASE explained in plain language.
Never miss a new study
Get alerted when new PARKINSONS DISEASE trials appear
Sign up with your email to follow new studies for PARKINSONS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Nerve graft brain implant trial launches for Parkinson's and MSA
Disease control Recruiting nowThis early-stage study tests whether implanting a small piece of the participant's own leg nerve into a key brain area is safe and feasible for people with early Parkinson's disease or Multiple System Atrophy. Seven volunteers will take part; four will receive the nerve graft and…
Matched conditions: PARKINSONS DISEASE
Phase: PHASE1 • Sponsor: Craig van Horne, MD, PhD • Aim: Disease control
Last updated May 07, 2026 14:31 UTC
-
Sound waves open brain barrier to deliver Parkinson's drug in early trial
Disease control Recruiting nowThis early study tests if a focused ultrasound technique can safely open the blood-brain barrier to deliver a Parkinson's drug (GCase) directly to a key brain area. About 14 people with Parkinson's will receive the treatment. The goal is to see if this approach is safe and feasib…
Matched conditions: PARKINSONS DISEASE
Phase: NA • Sponsor: InSightec • Aim: Disease control
Last updated May 05, 2026 11:54 UTC
-
New registry to monitor ultrasound brain treatment for Parkinson's
Disease control Recruiting nowThis study is a registry that will follow 60 people with advanced Parkinson's disease who are receiving a treatment called Exablate. The treatment uses focused ultrasound to target a small area in the brain to help control movement problems that medication no longer helps. Resear…
Matched conditions: PARKINSONS DISEASE
Sponsor: InSightec • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
New drug targets Parkinson's protein in Early-Stage trial
Disease control Recruiting nowThis study tests an experimental drug called ALN-SNCA in 46 people with early Parkinson's disease. The drug aims to lower a harmful protein (alpha-synuclein) in the fluid around the brain and spinal cord. The main goal is to check if the drug is safe and tolerable, and to see how…
Matched conditions: PARKINSONS DISEASE
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
Which anesthesia is better for Parkinson's battery surgery?
Symptom relief Recruiting nowThis study looks at two ways to manage pain during battery replacement surgery for deep brain stimulators in people with Parkinson's disease. Researchers will compare regional anesthesia (numbing a specific area) with general anesthesia (being fully asleep) to see which leads to …
Matched conditions: PARKINSONS DISEASE
Phase: NA • Sponsor: Ankara Etlik City Hospital • Aim: Symptom relief
Last updated May 06, 2026 16:14 UTC
-
Mindfulness duo: a new hope for Parkinson's patients and their families
Symptom relief Recruiting nowThis study tests whether an 8-week mindfulness program for people with Parkinson's and their family caregivers can reduce stress, anxiety, and depression while improving their relationship and quality of life. About 200 Chinese patient-caregiver pairs will either join the program…
Matched conditions: PARKINSONS DISEASE
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated May 04, 2026 16:22 UTC
-
Brain scan study aims to sharpen deep brain stimulation for Parkinson's
Knowledge-focused Recruiting nowThis study looks at brain activity in 100 adults with Parkinson's disease who already have a deep brain stimulation (DBS) device. Researchers will use brain scans and tests of movement and thinking to understand how different brain circuits work. The goal is to gather knowledge t…
Matched conditions: PARKINSONS DISEASE
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated May 04, 2026 16:30 UTC